lactic acid has been researched along with Opioid-Related Disorders in 3 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Opioid-Related Disorders: Disorders related to or resulting from abuse or misuse of OPIOIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Methadone serum levels were maintained around 200 ng/ml during 1 week and approximately 5 weeks with the optimised implants." | 1.32 | Methadone implants for methadone maintenance treatment. In vitro and in vivo animal studies. ( Delgado, A; Evora, C; Llabrés, M; Negrín, CM, 2004) |
| "Buprenorphine has been used for several years for the treatment of opiate addiction." | 1.30 | Development of biodegradable drug delivery system to treat addiction. ( Mandal, TK, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zuckerman, M | 1 |
| Vo, T | 1 |
| Negrín, CM | 1 |
| Delgado, A | 1 |
| Llabrés, M | 1 |
| Evora, C | 1 |
| Mandal, TK | 1 |
3 other studies available for lactic acid and Opioid-Related Disorders
| Article | Year |
|---|---|
Recurrent Ethylene Glycol Poisoning with Elevated Lactate Levels to Obtain Opioid Medications.
Topics: Adult; Analgesics, Opioid; Ethylene Glycol; Humans; Lactic Acid; Male; Malingering; Opioid-Related D | 2018 |
Methadone implants for methadone maintenance treatment. In vitro and in vivo animal studies.
Topics: Animals; Biocompatible Materials; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug I | 2004 |
Development of biodegradable drug delivery system to treat addiction.
Topics: Absorbable Implants; Biocompatible Materials; Buprenorphine; Delayed-Action Preparations; Drug Compo | 1999 |